[go: up one dir, main page]

GT201000166A - Aminotiazoles y sus usos - Google Patents

Aminotiazoles y sus usos

Info

Publication number
GT201000166A
GT201000166A GT201000166A GT201000166A GT201000166A GT 201000166 A GT201000166 A GT 201000166A GT 201000166 A GT201000166 A GT 201000166A GT 201000166 A GT201000166 A GT 201000166A GT 201000166 A GT201000166 A GT 201000166A
Authority
GT
Guatemala
Prior art keywords
aminotiazoles
thermometrics
thermometro
rhythomethermal
piridine
Prior art date
Application number
GT201000166A
Other languages
English (en)
Inventor
Bushell Simon
Matthew J Lamarche
Leeds Jennifer
Whitehead Lewis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40377437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201000166(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201000166A publication Critical patent/GT201000166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

LA PRESENTE SOLICITUD DESCRIBE COMPUESTOS ORGÁNICOS QUE SON ÚTILES PARA EL TRATAMIENTO, LA PREVENCIÓN Y/O LA MEJORA DE ENFERMEDADES, EN PARTICULAR INFECCIONES BACTERIANAS, DERIVADOS DE AMINOTIAZOLES, Y SALES FARMACÉUTICAMENTE ACEPTABLES, ENANTIÓMEROS, ESTEREOISÓMEROS, ROTÁMEROS, TAUTÓMEROS, DIASTEREÓMEROS, ATROPISÓMEROS O RACEMATOS DE LOS MISMOS, INCLUYENDO SU N-ÓXIDO DE PIRIDINA.
GT201000166A 2007-12-12 2010-06-10 Aminotiazoles y sus usos GT201000166A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1312207P 2007-12-12 2007-12-12
US2470908P 2008-01-30 2008-01-30

Publications (1)

Publication Number Publication Date
GT201000166A true GT201000166A (es) 2012-04-30

Family

ID=40377437

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201000166A GT201000166A (es) 2007-12-12 2010-06-10 Aminotiazoles y sus usos

Country Status (26)

Country Link
US (4) US8426356B2 (es)
EP (1) EP2229386B1 (es)
JP (2) JP5286366B2 (es)
KR (2) KR101187111B1 (es)
CN (1) CN101945866B (es)
AR (1) AR069628A1 (es)
AU (1) AU2008334659A1 (es)
BR (1) BRPI0821138A2 (es)
CA (1) CA2708793C (es)
CL (1) CL2008003688A1 (es)
CO (1) CO6290661A2 (es)
CR (1) CR11469A (es)
CU (1) CU20100119A7 (es)
EA (2) EA020205B1 (es)
EC (1) ECSP10010244A (es)
ES (1) ES2542878T3 (es)
GT (1) GT201000166A (es)
HN (1) HN2010001176A (es)
IL (1) IL206104A (es)
MA (1) MA31869B1 (es)
MY (1) MY156466A (es)
NZ (1) NZ585788A (es)
PE (1) PE20091108A1 (es)
TN (1) TN2010000254A1 (es)
TW (1) TWI430804B (es)
WO (1) WO2009074605A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
ES2542878T3 (es) * 2007-12-12 2015-08-12 Novartis Ag Un derivado de aminotiazol como agente antibacteriano
WO2016081825A1 (en) 2014-11-21 2016-05-26 KamTek, Inc. Methods and compositions for treating clostridium difficile associated disease

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202241A (en) 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ATE117724T1 (de) 1989-07-04 1995-02-15 Lepetit Spa Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
ES2071143T3 (es) 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
EP0529410B1 (en) 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Antibiotic GE 2270 factor C2a
US5882900A (en) 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
DE69317058T2 (de) 1992-12-22 1998-06-10 Biosearch Italia Spa Die antibiotika ge 37468 a, b und c
AU3805295A (en) 1994-11-08 1996-05-31 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d2
DK0808326T3 (da) 1995-02-07 2001-10-01 Biosearch Italia Spa Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika
DE69600244T2 (de) 1995-02-07 1998-10-01 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
JP2000505438A (ja) 1996-02-14 2000-05-09 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体
JPH1059997A (ja) 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
EP1553967B1 (en) 2002-06-17 2011-05-18 NAICONS s.c.a.r.l. Use of amide derivative of ge 2270 factor a3 for the treatment of acne
CA2580882A1 (en) 2004-09-22 2006-08-17 Merck & Co., Inc. Antibiotic compound
WO2007007399A1 (ja) * 2005-07-13 2007-01-18 Taisho Pharmaceutical Co., Ltd. チアゾール系化合物
AR060977A1 (es) 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
ATE500259T1 (de) 2006-12-20 2011-03-15 Novartis Ag Aminothiazolmakrocyclen, ihre verwendung als antibakterielle verbindungen und verfahren zu ihrer herstellung
MX2009013214A (es) 2007-06-04 2010-01-15 Novartis Ag Macrociclos y sus usos.
ES2542878T3 (es) * 2007-12-12 2015-08-12 Novartis Ag Un derivado de aminotiazol como agente antibacteriano

Also Published As

Publication number Publication date
KR101187111B1 (ko) 2012-09-28
CA2708793C (en) 2016-06-21
JP2013189468A (ja) 2013-09-26
EA201000890A1 (ru) 2011-02-28
CN101945866B (zh) 2013-06-19
ES2542878T3 (es) 2015-08-12
JP5286366B2 (ja) 2013-09-11
CR11469A (es) 2010-07-09
US9492496B2 (en) 2016-11-15
JP2011506394A (ja) 2011-03-03
US20140274878A1 (en) 2014-09-18
BRPI0821138A2 (pt) 2015-06-16
CN101945866A (zh) 2011-01-12
IL206104A (en) 2015-03-31
MA31869B1 (fr) 2010-11-01
US20130231275A1 (en) 2013-09-05
US20090156628A1 (en) 2009-06-18
CU20100119A7 (es) 2011-10-14
KR20120047335A (ko) 2012-05-11
AR069628A1 (es) 2010-02-03
ECSP10010244A (es) 2010-07-30
NZ585788A (en) 2011-07-29
CL2008003688A1 (es) 2009-06-19
TN2010000254A1 (en) 2011-11-11
KR20100090809A (ko) 2010-08-17
US8426356B2 (en) 2013-04-23
CO6290661A2 (es) 2011-06-20
HN2010001176A (es) 2012-12-10
TW200932256A (en) 2009-08-01
CU23908B1 (es) 2013-06-28
EP2229386A1 (en) 2010-09-22
IL206104A0 (en) 2010-11-30
US20170015704A1 (en) 2017-01-19
PE20091108A1 (es) 2009-08-24
AU2008334659A1 (en) 2009-06-18
EP2229386B1 (en) 2015-06-03
CA2708793A1 (en) 2009-06-18
EA020205B1 (ru) 2014-09-30
MY156466A (en) 2016-02-26
WO2009074605A1 (en) 2009-06-18
EA201400280A1 (ru) 2014-08-29
TWI430804B (zh) 2014-03-21

Similar Documents

Publication Publication Date Title
CR10336A (es) Compuestos organicos y sus usos
UY32123A (es) Derivados de n - (sustituido) - 4 - (but-2-iniloxi) - benzamida, sus racematos, diastereòmeros, enantiòmeros y las sales de los mismos y aplicaciones
CR10433A (es) Compuestos organicos y sus usos
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
UY32551A (es) Compuestos peptidomiméticos de sulfamida y usos antivirales de los mismos
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
CL2007002100A1 (es) Compuestos derivados biciclicos que contienen nitrogeno, sus sales, solvatos y n-oxidos; composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
UY32554A (es) Compuestos peptidomiméticos de sulfonamida y usos antivirales de los mismos
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
CR20110202A (es) Antagonistas de la via hedgehog de ftalazina disustituida
ECSP088922A (es) Derivados de amino-tiazol y sus usos como agentes antibacterianos
SV2011003839A (es) Agentes antifungicos
CL2011002625A1 (es) Compuestos derivados de 3-(piridin-3-il-etinil)-piridina; preparaciones farmaceuticas que los contienen; y su uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
ECSP099836A (es) Macrociclos y sus usos
GT201000166A (es) Aminotiazoles y sus usos
AR060402A1 (es) Compuestos organicos y sus usos
CL2012001758A1 (es) Uso de compuestos derivados de 8-hidroxiquinolin-7-carboxamida y sus sales, para el tratamiento y/o prevencion de infecciones fungicas.
CY1114753T1 (el) Παραγωγα αμινοθειαζολιου και οι χρησεις τους ως αντιβακτηριακοι παραγοντες